IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target

Systemic lupus erythematosus (SLE) is a multifactorial chronic autoimmune disease, marked by the presence of autoantibodies to nuclear antigens belonging to different isotype classes. For several years, IgE antibodies have been incriminated in the development of allergic diseases and parasitic infec...

Full description

Bibliographic Details
Main Authors: Yasmine Lamri, Nicolas Charles
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Antibodies
Subjects:
SLE
IgE
Online Access:https://www.mdpi.com/2073-4468/9/4/69
id doaj-35ed1f1748d94153a8fb70d962e6104b
record_format Article
spelling doaj-35ed1f1748d94153a8fb70d962e6104b2020-12-09T00:04:12ZengMDPI AGAntibodies2073-44682020-12-019696910.3390/antib9040069IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic TargetYasmine Lamri0Nicolas Charles1Centre de Recherche sur l’Inflammation, CNRS ERL8252 Faculté de Médecine Site Bichat, Université de Paris, INSERM UMR1149, 16 rue Henri Huchard, F-75018 Paris, FranceCentre de Recherche sur l’Inflammation, CNRS ERL8252 Faculté de Médecine Site Bichat, Université de Paris, INSERM UMR1149, 16 rue Henri Huchard, F-75018 Paris, FranceSystemic lupus erythematosus (SLE) is a multifactorial chronic autoimmune disease, marked by the presence of autoantibodies to nuclear antigens belonging to different isotype classes. For several years, IgE antibodies have been incriminated in the development of allergic diseases and parasitic infections and different anti-IgE therapies have been developed to encounter the pathogenic role of IgE in these pathologies. Recently, multiple studies showed the presence of elevated total IgE levels and demonstrated a pathogenic role of autoreactive IgE in SLE. This review aims to summarize the findings incriminating IgE and autoreactive IgE in the pathophysiology of SLE, to describe their functional outcomes on their targeted cells as well as to discuss different IgE-related therapeutic modalities that emerged and that may be beneficial for SLE patient care.https://www.mdpi.com/2073-4468/9/4/69autoantibodiesisotypeslupusSLEFc receptorsIgE
collection DOAJ
language English
format Article
sources DOAJ
author Yasmine Lamri
Nicolas Charles
spellingShingle Yasmine Lamri
Nicolas Charles
IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target
Antibodies
autoantibodies
isotypes
lupus
SLE
Fc receptors
IgE
author_facet Yasmine Lamri
Nicolas Charles
author_sort Yasmine Lamri
title IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target
title_short IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target
title_full IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target
title_fullStr IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target
title_full_unstemmed IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target
title_sort ige in the pathogenesis of sle: from pathogenic role to therapeutic target
publisher MDPI AG
series Antibodies
issn 2073-4468
publishDate 2020-12-01
description Systemic lupus erythematosus (SLE) is a multifactorial chronic autoimmune disease, marked by the presence of autoantibodies to nuclear antigens belonging to different isotype classes. For several years, IgE antibodies have been incriminated in the development of allergic diseases and parasitic infections and different anti-IgE therapies have been developed to encounter the pathogenic role of IgE in these pathologies. Recently, multiple studies showed the presence of elevated total IgE levels and demonstrated a pathogenic role of autoreactive IgE in SLE. This review aims to summarize the findings incriminating IgE and autoreactive IgE in the pathophysiology of SLE, to describe their functional outcomes on their targeted cells as well as to discuss different IgE-related therapeutic modalities that emerged and that may be beneficial for SLE patient care.
topic autoantibodies
isotypes
lupus
SLE
Fc receptors
IgE
url https://www.mdpi.com/2073-4468/9/4/69
work_keys_str_mv AT yasminelamri igeinthepathogenesisofslefrompathogenicroletotherapeutictarget
AT nicolascharles igeinthepathogenesisofslefrompathogenicroletotherapeutictarget
_version_ 1724388615315783680